Clinical Features and Prognosis of CD20 Negative Aggressive B-Cell Non-Hodgkins Lymphoma

Table 2

Immunophenotypic features of patients with plasmablastic DLBCL.

	CD20	CD79	Ki-67	CD10	Bcl-6	Bcl-2	CD138	EBV	FISH for MYC/IgH
(1)	−	+	40%	−	+	−	+	n/a	n/a
(2)	−	+	100%	−	−	−	+	n/a	n/a
(3)	−	+	85%	+	n/a	−	+	−	−
(4)	−	n/a	100%	+	−	−	+	+	+
(5)	−	n/a	n/a	−	n/a	n/a	+	+	+

n/a: not available; −: negative; +: positive.